Vistaril / Atarax Withdrawal & Tapering Guide
hydroxyzine
In short
Vistaril / Atarax (hydroxyzine) is an Other with a half-life of ~20 hours. Most patients can stop with a brief 1-week step-down or directly. Withdrawal symptoms, when they occur, usually begin 1-3 days and settle within 1-2 weeks. It is also sold as Vistaril, Atarax.
- Class
- Other
- Half-life
- ~20 hours
- Common doses
- 10mg, 25mg, 50mg, 100mg tablets/capsules; 10mg/5mL syrup
- Withdrawal onset
- 1-3 days
- Typical resolution
- 1-2 weeks
Educational reference only. Dose changes are decided with the prescriber who knows your history.
Overview
Hydroxyzine is a first-generation antihistamine used as an anxiolytic, antipruritic, and pre-anesthetic. Non-controlled, non-dependence-forming, often chosen as a benzodiazepine-sparing option for short-term anxiety.
10mg, 25mg, 50mg, 100mg tablets/capsules; 10mg/5mL syrup
Tablets/capsules: 10mg, 25mg, 50mg, 100mg; Syrup: 10mg/5mL; IM injection
Category C
Mechanism of Action
Potent histamine H1 antagonist; mild muscarinic and 5-HT2A antagonism. The active metabolite cetirizine accounts for some of the long-acting effect.
Taper Notes
Most patients can stop with a brief 1-week step-down or directly. No benzodiazepine-style withdrawal.
Hyperbolic Tapering Guidance
A genuinely low-risk discontinuation profile compared with benzodiazepines or Z-drugs.
Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.
Withdrawal Timeline
1-3 days
3-7 days
1-2 weeks
Rare
Common Withdrawal Symptoms
Interactions & Safety
Drug Interactions
- Other CNS depressants — additive sedation
- Anticholinergics — additive burden
- QT-prolonging drugs — additive risk
Contraindications
- Known QT prolongation
- Severe sedation risk patients
Toxicity
Sedation, dry mouth, dizziness, blurred vision, urinary retention. QT prolongation at higher doses or in combination with other QT-prolonging drugs.
Pharmacokinetics
ADME Profile
Hepatic to cetirizine and other metabolites.
~93%
Need a clinician who understands tapering?
Browse our map of deprescribing-informed providers worldwide.
Related Articles About Vistaril / Atarax
Other Drug Profiles
Frequently asked questions about Vistaril / Atarax
What are the withdrawal symptoms of Vistaril / Atarax (hydroxyzine)?
Common withdrawal symptoms of Vistaril / Atarax (hydroxyzine) include: mild rebound anxiety, rebound insomnia, usually minimal. Symptom severity varies by individual, dose, and duration of use.
How should I taper off Vistaril / Atarax (hydroxyzine)?
Most patients can stop with a brief 1-week step-down or directly. No benzodiazepine-style withdrawal. A genuinely low-risk discontinuation profile compared with benzodiazepines or Z-drugs.
How long does Vistaril / Atarax withdrawal last?
Vistaril / Atarax withdrawal typically begins 1-3 days, peaks around 3-7 days, and resolves within 1-2 weeks. Rare
Can I stop Vistaril / Atarax cold turkey?
Stopping Vistaril / Atarax abruptly is not recommended. Its half-life is ~20 hours, and the receptor adaptations built up during treatment do not reverse at that speed, so a sudden stop tends to produce the sharpest withdrawal. Prescribing guidance favours gradual, proportional reductions agreed with your prescriber.
How long does Vistaril / Atarax stay in your system?
Vistaril / Atarax (hydroxyzine) has a half-life of ~20 hours. A drug is mostly cleared after about five half-lives, so Vistaril / Atarax is largely out of the body about 4 days after the last dose, longer in older adults or with liver or kidney impairment. Withdrawal symptoms often begin before the drug has fully cleared and continue after it has, because the adaptations the brain made during treatment reverse more slowly than the drug leaves the blood.
Sources & References
Vistaril / Atarax (hydroxyzine) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.
Encyclopedic & chemical databases
Neutral, high-authority entity references.
Regulatory sources
Official prescribing information and safety notices.
Peer-reviewed research
Primary literature cited in this taper guide.
Clinical guidelines
Evidence-based deprescribing and prescribing standards.
Deprescribing-specific resources
Clinician-facing references on tapering protocols.
- Deprescribing.org — Evidence-based deprescribing algorithms from the Bruyère Research Institute
- Royal College of Psychiatrists — Stopping antidepressants — UK clinical guidance on safely discontinuing antidepressants
Patient-advocacy & lived-experience
Long-running communities documenting withdrawal experience.
- Surviving Antidepressants — tapering forum — Long-running community archive of antidepressant taper experiences
- Inner Compass Initiative — Withdrawal Project — Peer-led resources for psychiatric drug withdrawal
- Mad in America — antidepressant withdrawal archive — Journalism and personal narratives on SSRI/SNRI discontinuation
- RxISK — adverse drug reaction reporting — Independent database of patient-reported adverse effects
TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.